JP Morgan Maintains Overweight on CVS Health, Raises Price Target to $111

Benzinga Newsdesk www.benzinga.com Positive 75.0%

Neg 0% Neu 0% Pos 75%

JP Morgan analyst Lisa Gill maintains CVS Health (NYSE:CVS) with a Overweight and raises the price target from $101 to $111.